B-cell receptor (BCR)-ABL translocation and the Philadelphia chromosome.
On the left, the substrate with phosphorylated tyrosine (Y) is activated by BCR-ABL. Tyrosine kinase inhibitor (TKI) prevents phosphorylation, hence activation, of the substrates (see also Figure 11.10).